• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

紫杉醇涂层球囊与药物洗脱支架治疗初发冠状动脉病变时围手术期心肌梗死的比较

A Comparison of Peri-Procedural Myocardial Infarction between Paclitaxel-Coated Balloon and Drug-Eluting Stent on De Novo Coronary Lesions.

作者信息

Her Ae Young, Cho Kyoung Im, Singh Gillian Balbir, Garg Scot, Kim Yong Hoon, Koo Bon Kwon, Shin Eun Seok

机构信息

Division of Cardiology, Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon, Korea.

Division of Cardiology, Department of Internal Medicine, Kosin University Gospel Hospital, Busan, Korea.

出版信息

Yonsei Med J. 2017 Jan;58(1):99-104. doi: 10.3349/ymj.2017.58.1.99.

DOI:10.3349/ymj.2017.58.1.99
PMID:27873501
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5122659/
Abstract

PURPOSE

This study compared the impact of paclitaxel-coated balloons (PCB) or drug eluting stents (DES) on peri-procedural myocardial infarction (PMI) on de novo coronary lesion in stable patients.

MATERIALS AND METHODS

In this observational study, we compared the incidence of PMI amongst patients with single vessel de novo coronary lesions who underwent treatment with a PCB or DES. Propensity score-matching analysis was used to assemble a cohort of patients with similar baseline characteristics. PMI was classified as myocardial infarction occurring within 48 hours after percutaneous coronary intervention with a threshold of 5 x the 99th percentile upper reference limit of normal for creatine kinase-myocardial band (CK-MB) or troponin T (TnT).

RESULTS

One hundred four patients (52 receiving PCB and 52 receiving DES) were enrolled in this study. The peak mean values of CK-MB and TnT were significantly higher in the DES group. There was a significantly higher rate of PMI in the DES group (23.1% vs. 1.9%, p=0.002). Total occlusion of the side-branch occurred in two patients treated with DES, while no patients treated with PCB. In multivariable analysis, DES was the only independent predictor of PMI compared with PCB (odds ratio 42.85, 95% confidence interval: 3.44-533.87, p=0.004).

CONCLUSION

Treatment with a PCB on de novo coronary lesion might be associated with a significant reduction in the risk of PMI compared to DES.

摘要

目的

本研究比较了紫杉醇涂层球囊(PCB)或药物洗脱支架(DES)对稳定型患者新发冠状动脉病变围手术期心肌梗死(PMI)的影响。

材料与方法

在这项观察性研究中,我们比较了接受PCB或DES治疗的单支新发冠状动脉病变患者中PMI的发生率。采用倾向评分匹配分析来组建一组具有相似基线特征的患者。PMI被定义为在经皮冠状动脉介入治疗后48小时内发生的心肌梗死,其阈值为肌酸激酶心肌型(CK-MB)或肌钙蛋白T(TnT)正常上限参考值的99百分位数的5倍。

结果

本研究共纳入104例患者(52例接受PCB治疗,52例接受DES治疗)。DES组CK-MB和TnT的峰值均值显著更高。DES组的PMI发生率显著更高(23.1%对1.9%,p=0.002)。接受DES治疗的2例患者出现了侧支血管完全闭塞,而接受PCB治疗的患者中未出现。在多变量分析中,与PCB相比,DES是PMI的唯一独立预测因素(比值比42.85,95%置信区间:3.44-533.87,p=0.004)。

结论

与DES相比,用PCB治疗新发冠状动脉病变可能与PMI风险的显著降低相关。

相似文献

1
A Comparison of Peri-Procedural Myocardial Infarction between Paclitaxel-Coated Balloon and Drug-Eluting Stent on De Novo Coronary Lesions.紫杉醇涂层球囊与药物洗脱支架治疗初发冠状动脉病变时围手术期心肌梗死的比较
Yonsei Med J. 2017 Jan;58(1):99-104. doi: 10.3349/ymj.2017.58.1.99.
2
Impact of paclitaxel-coated balloon versus newer-generation drug-eluting stent on periprocedural myocardial infarction in stable angina patients.
Coron Artery Dis. 2018 Aug;29(5):403-408. doi: 10.1097/MCA.0000000000000620.
3
Incidence and Potential Mechanism(s) of Post-Procedural Rise of Cardiac Biomarker in Patients With Coronary Artery Narrowing After Implantation of an Everolimus-Eluting Bioresorbable Vascular Scaffold or Everolimus-Eluting Metallic Stent.生物可吸收雷帕霉素洗脱血管支架或雷帕霉素洗脱金属支架置入后冠状动脉狭窄患者术后心脏生物标志物升高的发生率及潜在机制。
JACC Cardiovasc Interv. 2015 Jul;8(8):1053-1063. doi: 10.1016/j.jcin.2015.06.001.
4
Incidence of periprocedural myocardial infarction following stent implantation: comparison between first- and second-generation drug-eluting stents.支架植入术后围手术期心肌梗死的发生率:第一代和第二代药物洗脱支架的比较。
Catheter Cardiovasc Interv. 2012 Oct 1;80(4):524-30. doi: 10.1002/ccd.23334. Epub 2011 Dec 2.
5
Incidence, predicting factors, and clinical outcomes of periprocedural myocardial infarction after percutaneous coronary intervention for chronic total occlusion in the era of new-generation drug-eluting stents.新一代药物洗脱支架时代经皮冠状动脉介入治疗慢性完全闭塞病变后围术期心肌梗死的发生率、预测因素及临床转归。
Catheter Cardiovasc Interv. 2018 Sep 1;92(3):477-485. doi: 10.1002/ccd.27420. Epub 2017 Dec 20.
6
Periprocedural myocardial infarction is associated with increased mortality in patients with coronary artery bifurcation lesions after implantation of a drug-eluting stent.围手术期心肌梗死与药物洗脱支架植入术后冠状动脉分叉病变患者死亡率增加相关。
Catheter Cardiovasc Interv. 2015 Mar;85 Suppl 1:696-705. doi: 10.1002/ccd.25857.
7
Paclitaxel-coated balloon for the treatment of drug-eluting stent restenosis: subanalysis results from the Valentines I trial.用于治疗药物洗脱支架再狭窄的紫杉醇涂层球囊:情人节 I 试验的亚组分析结果
Cardiovasc Revasc Med. 2014 Jan;15(1):23-8. doi: 10.1016/j.carrev.2013.08.011.
8
Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).紫杉醇涂层球囊与球囊血管成形术治疗的长期结果:PEPCAD-DES 研究的见解(使用 SeQuent Please 紫杉醇涂层经皮腔内冠状动脉血管成形术 [PTCA] 导管治疗药物洗脱支架 [DES] 支架内再狭窄)。
JACC Cardiovasc Interv. 2015 Nov;8(13):1695-700. doi: 10.1016/j.jcin.2015.07.023.
9
Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis.经皮分叉介入治疗患者术前 C 反应蛋白水平与围手术期心肌损伤的相关性:CACTUS 研究的亚组分析。
Catheter Cardiovasc Interv. 2014 Jan 1;83(1):E37-44. doi: 10.1002/ccd.25102. Epub 2013 Aug 5.
10
Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.替罗非班在置入药物洗脱支架的稳定型患者择期经皮冠状动脉介入治疗长冠状动脉病变围手术期的应用——PETITION研究:一项前瞻性、随机、多中心研究
Catheter Cardiovasc Interv. 2015 Mar;85 Suppl 1:762-9. doi: 10.1002/ccd.25864.

引用本文的文献

1
Drug-Coated Balloon-Only Percutaneous Coronary Intervention for the Treatment of De Novo Coronary Artery Disease: A Systematic Review.单纯药物涂层球囊经皮冠状动脉介入治疗初发冠状动脉疾病的系统评价
Cardiol Ther. 2018 Dec;7(2):127-149. doi: 10.1007/s40119-018-0121-2. Epub 2018 Oct 27.

本文引用的文献

1
Serial Morphological Changes of Side-Branch Ostium after Paclitaxel-Coated Balloon Treatment of De Novo Coronary Lesions of Main Vessels.紫杉醇涂层球囊治疗主血管初发冠状动脉病变后侧支开口的系列形态学变化
Yonsei Med J. 2016 May;57(3):606-13. doi: 10.3349/ymj.2016.57.3.606.
2
Comparison of Paclitaxel-Coated Balloon Treatment and Plain Old Balloon Angioplasty for De Novo Coronary Lesions.紫杉醇涂层球囊治疗与普通球囊血管成形术治疗初发冠状动脉病变的比较
Yonsei Med J. 2016 Mar;57(2):337-41. doi: 10.3349/ymj.2016.57.2.337.
3
Fractional flow reserve-guided paclitaxel-coated balloon treatment for de novo coronary lesions.血流储备分数引导的紫杉醇涂层球囊治疗初发冠状动脉病变
Catheter Cardiovasc Interv. 2016 Aug;88(2):193-200. doi: 10.1002/ccd.26257. Epub 2015 Oct 1.
4
Periprocedural myocardial infarction is associated with increased mortality in patients with coronary artery bifurcation lesions after implantation of a drug-eluting stent.围手术期心肌梗死与药物洗脱支架植入术后冠状动脉分叉病变患者死亡率增加相关。
Catheter Cardiovasc Interv. 2015 Mar;85 Suppl 1:696-705. doi: 10.1002/ccd.25857.
5
Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention.经皮冠状动脉介入治疗后围手术期心肌梗死的频率、原因、预测因素及临床意义。
Eur Heart J. 2013 Jun;34(22):1662-9. doi: 10.1093/eurheartj/eht048. Epub 2013 Feb 12.
6
Third universal definition of myocardial infarction.心肌梗死的第三次全球定义。
J Am Coll Cardiol. 2012 Oct 16;60(16):1581-98. doi: 10.1016/j.jacc.2012.08.001. Epub 2012 Sep 5.
7
Myocardial infarction due to percutaneous coronary intervention.经皮冠状动脉介入治疗所致心肌梗死
N Engl J Med. 2011 Feb 3;364(5):453-64. doi: 10.1056/NEJMra0912134.
8
Periprocedural myocardial infarction: prevalence, prognosis, and prevention.围手术期心肌梗死:患病率、预后及预防
Circ Cardiovasc Interv. 2010 Dec;3(6):602-10. doi: 10.1161/CIRCINTERVENTIONS.110.959080.
9
Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection.经皮冠状动脉介入治疗围术期心肌损伤:心脏保护的重要靶点。
Eur Heart J. 2011 Jan;32(1):23-31. doi: 10.1093/eurheartj/ehq393. Epub 2010 Oct 29.
10
Periprocedural myocardial injury during elective percutaneous coronary intervention: is it important and how can it be prevented?择期经皮冠状动脉介入治疗期间的围术期心肌损伤:重要吗?如何预防?
Heart. 2010 May;96(10):736-40. doi: 10.1136/hrt.2009.186189.